Relmada Therapeutics ( ($RLMD) ) has shared an announcement. On September 17, 2025, Relmada Therapeutics updated its corporate presentation, ...

Featured presentations showcase the positive Phase 1 healthy volunteer trial results supporting KT-621’s oral, dupilumab-like profileKT-621 ...

Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today ...

Imperative Care, Inc. announces positive results from the SYMPHONY-PE Trial evaluating Symphony® Thrombectomy System in the ...

HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of ...

VIJAYAWADA: The Government of Andhra Pradesh hosted a high-profile Investor Roadshow late Tuesday night in London at the ...

Disney’s ABC said “Jimmy Kimmel Live!” “will be will be pre-empted indefinitely,” a spokesperson confirmed to NBC News, after ...

Protagonist Therapeutics (PTGX) announced new data from the Phase 3 ICONIC-ADVANCE 1 and 2 studies which assessed the superiority of icotrokinra, ...

Data show a favorable safety profile and early efficacy signals in a heavily pre-treated population whose cancer progressed after multiple prior ...

Soleno Therapeutics faces scrutiny over Vykat safety after a patient death. Click here to find out why I rate SLNO a Hold.

Craving a reliable ribeye or a locally-loved specialty? These Virginia steakhouses deliver familiar favorites and ...

LightPath Technologies, Inc. stock soared 120% with BlackDiamond tech, key acquisitions, and new markets. Click here to read ...